<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02547623</url>
  </required_header>
  <id_info>
    <org_study_id>C15-01</org_study_id>
    <nct_id>NCT02547623</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery</brief_title>
  <official_title>A Phase 3, Prospective, Randomized, Parallel-design, Multicenter Study to Evaluate the Safety of Icon Bioscience-10090 for the Treatment of Inflammation Associated With Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ICON Bioscience Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ICON Bioscience Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective, randomized, parallel-design, multicenter trial in patients ≥40
      years of age undergoing cataract surgery. Patients who meet all inclusion and no exclusion
      criteria will be randomized to 1 of 2 treatment groups

        -  A single 5 mcl anterior chamber injection of IBI 10090, 103.4 mcg/mcl dexamethasone,
           equivalent dexamethasone dose: 517 mcg at the conclusion of cataract surgery or;

        -  Prednisolone acetate ophthalmic suspension 1% eye drops administered 1 drop 4 times
           daily (QID) for 3 weeks Safety will be assessed by adverse events (AEs), slit lamp
           biomicroscopy, fundus examination, intraocular pressure (IOP), visual acuity, and
           specular microscopy endothelial cell count.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, randomized, parallel-design, multicenter trial in patients ≥40
      years of age undergoing cataract surgery. Patients who meet all inclusion and no exclusion
      criteria will be randomized to 1 of 2 treatment groups

        -  A single 5 mcl anterior chamber injection of IBI 10090, 103.4 mcg/mcl dexamethasone,
           equivalent dexamethasone dose: 517 mcg at the conclusion of cataract surgery or;

        -  Prednisolone acetate ophthalmic suspension 1% eye drops administered 1 drop 4 times
           daily (QID) for 3 weeks
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2015</start_date>
  <completion_date type="Actual">August 16, 2016</completion_date>
  <primary_completion_date type="Actual">August 16, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Treatment-Emergent Adverse Events (TEAEs)</measure>
    <time_frame>Baseline to postoperative day 90/ early termination</time_frame>
    <description>Treatment-emergent Adverse Events were defined as events that started after the study drug administration, and occurred before termination of the study, or were present before study drug administration and worsened after dose administration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraocular Pressure Measurement</measure>
    <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
    <description>Intraocular Pressure was measured by Goldmann applanation tonometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity in Study Eye</measure>
    <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
    <description>Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Slit Lamp Biomicroscopy - Conjunctival Hyperemia Grade</measure>
    <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
    <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Conjunctiva hyperemia slit lamp results were summarized by treatment group and time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Slit Lamp Biomicroscopy - Cornea Edema Grade</measure>
    <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
    <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Cornea edema slit lamp results in the study eye were summarized by treatment group and time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of Concomitant Medications Used in the Study Eye or Both Eyes</measure>
    <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Corneal Endothelial Cell Count</measure>
    <time_frame>Baseline, Postoperative day 90/Early termination</time_frame>
    <description>Corneal Endothelial Cell Density was measured by specular microscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optic Disc Cup-disc Ratio for the Study Eye</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>Calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dilated Opthalmoscopy Findings - Optic Disc (Study Eye)</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's optic disc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dilated Opthalmoscopy Findings - Retina (Study Eye)</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's retina</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dilated Opthalmoscopy Findings - Macula (Study Eye)</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's macula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dilated Opthalmoscopy Findings - Choroid (Study Eye)</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's choroid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dilated Opthalmoscopy Findings - Vitreous (Study Eye)</measure>
    <time_frame>Baseline, POD 90/Early termination</time_frame>
    <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's vitreous</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>dexamethasone depot</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexamethasone depot 517 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prednisolone drops 1%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>depot intracameral</description>
    <arm_group_label>dexamethasone depot</arm_group_label>
    <other_name>Dexycu</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisolone</intervention_name>
    <description>Prednisolone eye drops 1%</description>
    <arm_group_label>standard of care</arm_group_label>
    <other_name>standard of care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing cataract surgery

        Exclusion Criteria:

          -  glaucoma patient, pregnancy, allergy to dexamethasone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Donnenfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthalmic Consultants of Long Island</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kislinger MD inc</name>
      <address>
        <city>Glendora</city>
        <state>California</state>
        <zip>91741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inland Eye Specialists</name>
      <address>
        <city>Hemet</city>
        <state>California</state>
        <zip>92545</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harvard Eye Associated</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Feinerman Vision Center</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Eye Institute</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associated Eye Care</name>
      <address>
        <city>Stillwater</city>
        <state>Minnesota</state>
        <zip>55082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matossian Eye Associates</name>
      <address>
        <city>Pennington</city>
        <state>New Jersey</state>
        <zip>08534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Garden City</city>
        <state>New York</state>
        <zip>11530</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Eye Institute</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Eye Care Physicians</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>the eye institute of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>September 9, 2015</study_first_submitted>
  <study_first_submitted_qc>September 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <results_first_submitted>April 6, 2018</results_first_submitted>
  <results_first_submitted_qc>May 21, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 19, 2018</results_first_posted>
  <last_update_submitted>July 24, 2018</last_update_submitted>
  <last_update_submitted_qc>July 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The first patient was enrolled into the study on 06 November 2015 and the last patient completed the study on 16 August 2016.</recruitment_details>
      <pre_assignment_details>Of the 194 patients randomized, 181 patients were dosed and included in the ITT (intent-to-treat) and safety analysis sets. 13 randomized patients were not dosed and terminated from the study. Some of the patients that were not dosed had at least one significant protocol deviation.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Dexamethasone Depot</title>
          <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
        </group>
        <group group_id="P2">
          <title>Prednisolone Drops 1% (Standard of Care)</title>
          <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dexamethasone Depot</title>
          <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
        </group>
        <group group_id="B2">
          <title>Prednisolone Drops 1% (Standard of Care)</title>
          <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="126"/>
            <count group_id="B2" value="55"/>
            <count group_id="B3" value="181"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="163"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Study Eye</title>
          <units>study eye</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>OD (Right eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OS (Left eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Best Corrected Visual Acuity</title>
          <description>Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1</description>
          <units>LogMar</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>study eye number</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".292" spread=".1913"/>
                    <measurement group_id="B2" value=".355" spread=".2557"/>
                    <measurement group_id="B3" value=".311" spread=".2141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>fellow eye number</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".126" spread=".1394"/>
                    <measurement group_id="B2" value=".176" spread=".2123"/>
                    <measurement group_id="B3" value=".141" spread=".1660"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Corneal Endothelial Cell Density - Specular Microscopy</title>
          <units>cells/mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2491.91" spread="346.365"/>
                    <measurement group_id="B2" value="2398.33" spread="384.092"/>
                    <measurement group_id="B3" value="2463.15" spread="359.902"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intraocular Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Study eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.1" spread="2.94"/>
                    <measurement group_id="B2" value="14.4" spread="2.71"/>
                    <measurement group_id="B3" value="14.9" spread="2.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fellow eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.9" spread="2.88"/>
                    <measurement group_id="B2" value="14.5" spread="2.79"/>
                    <measurement group_id="B3" value="14.8" spread="2.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Use of Viscoelastic during the Surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Use of Femto prior to the Surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Treatment-Emergent Adverse Events (TEAEs)</title>
        <description>Treatment-emergent Adverse Events were defined as events that started after the study drug administration, and occurred before termination of the study, or were present before study drug administration and worsened after dose administration.</description>
        <time_frame>Baseline to postoperative day 90/ early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment-Emergent Adverse Events (TEAEs)</title>
          <description>Treatment-emergent Adverse Events were defined as events that started after the study drug administration, and occurred before termination of the study, or were present before study drug administration and worsened after dose administration.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ocular events: study eye</title>
              <category_list>
                <category>
                  <title>Any TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Serious TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ocular events: fellow eye</title>
              <category_list>
                <category>
                  <title>Any TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Serious TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic events</title>
              <category_list>
                <category>
                  <title>Any TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Serious TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No TEAE</title>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraocular Pressure Measurement</title>
        <description>Intraocular Pressure was measured by Goldmann applanation tonometry.</description>
        <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure Measurement</title>
          <description>Intraocular Pressure was measured by Goldmann applanation tonometry.</description>
          <units>mmHG</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1" spread="2.94"/>
                    <measurement group_id="O2" value="14.4" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.1" spread="6.54"/>
                    <measurement group_id="O2" value="17.5" spread="6.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="4.7"/>
                    <measurement group_id="O2" value="15.1" spread="3.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="3.2"/>
                    <measurement group_id="O2" value="14.1" spread="3.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 90/End of Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0" spread="2.89"/>
                    <measurement group_id="O2" value="12.7" spread="2.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Acuity in Study Eye</title>
        <description>Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1</description>
        <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity in Study Eye</title>
          <description>Visual Acuity assessed by the Snellen chart, was expressed as the logarithm of the minimum angle of resolution (logMAR), and could range from 0 (representing 20/20 vision) to 1</description>
          <units>LogMar</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".292" spread="0.1913"/>
                    <measurement group_id="O2" value=".355" spread=".2557"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".249" spread=".1398"/>
                    <measurement group_id="O2" value=".327" spread=".2129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".073" spread=".1353"/>
                    <measurement group_id="O2" value=".073" spread=".1746"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".039" spread=".0952"/>
                    <measurement group_id="O2" value=".040" spread=".1350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Operative Day 90/End of Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".040" spread=".1012"/>
                    <measurement group_id="O2" value=".047" spread=".1150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Slit Lamp Biomicroscopy - Conjunctival Hyperemia Grade</title>
        <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Conjunctiva hyperemia slit lamp results were summarized by treatment group and time point.</description>
        <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Slit Lamp Biomicroscopy - Conjunctival Hyperemia Grade</title>
          <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Conjunctiva hyperemia slit lamp results were summarized by treatment group and time point.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 1</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="103"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 8</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="115"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 30</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of Treatment</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Slit Lamp Biomicroscopy - Cornea Edema Grade</title>
        <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Cornea edema slit lamp results in the study eye were summarized by treatment group and time point.</description>
        <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Slit Lamp Biomicroscopy - Cornea Edema Grade</title>
          <description>Slit lamp biomicroscopy of the anterior chamber was performed using a slit beam of 1-mm height and 1-mm width with maximum luminance through the highest-powered lens using the Investigator's standard slit lamp equipment and procedure.
Cornea edema slit lamp results in the study eye were summarized by treatment group and time point.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="126"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 1</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 8</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 30</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of Treatment</title>
              <category_list>
                <category>
                  <title>0 (Absent)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 (Mild)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 (Moderate)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 (Severe)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No value</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summary of Concomitant Medications Used in the Study Eye or Both Eyes</title>
        <time_frame>Baseline, Postoperative (POD) 1, POD 8, POD 30, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Summary of Concomitant Medications Used in the Study Eye or Both Eyes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients reporting at least one concomitant medica</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiseptics and disinfectants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anesthetics</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psycholeptics</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ophthalmologicals</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thyroid therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in the Corneal Endothelial Cell Count</title>
        <description>Corneal Endothelial Cell Density was measured by specular microscopy.</description>
        <time_frame>Baseline, Postoperative day 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in the Corneal Endothelial Cell Count</title>
          <description>Corneal Endothelial Cell Density was measured by specular microscopy.</description>
          <units>cells/mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2483.66" spread="351.819"/>
                    <measurement group_id="O2" value="2398.33" spread="384.092"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2141.77" spread="522.327"/>
                    <measurement group_id="O2" value="2106.39" spread="517.938"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-334.60" spread="415.071"/>
                    <measurement group_id="O2" value="-288.83" spread="376.775"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Optic Disc Cup-disc Ratio for the Study Eye</title>
        <description>Calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc).</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Optic Disc Cup-disc Ratio for the Study Eye</title>
          <description>Calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc).</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".31" spread=".142"/>
                    <measurement group_id="O2" value=".32" spread=".135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".31" spread=".131"/>
                    <measurement group_id="O2" value=".33" spread=".143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dilated Opthalmoscopy Findings - Optic Disc (Study Eye)</title>
        <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's optic disc</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Dilated Opthalmoscopy Findings - Optic Disc (Study Eye)</title>
          <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's optic disc</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="115"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dilated Opthalmoscopy Findings - Retina (Study Eye)</title>
        <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's retina</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Dilated Opthalmoscopy Findings - Retina (Study Eye)</title>
          <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's retina</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dilated Opthalmoscopy Findings - Macula (Study Eye)</title>
        <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's macula.</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Dilated Opthalmoscopy Findings - Macula (Study Eye)</title>
          <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's macula.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dilated Opthalmoscopy Findings - Choroid (Study Eye)</title>
        <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's choroid</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Dilated Opthalmoscopy Findings - Choroid (Study Eye)</title>
          <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's choroid</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dilated Opthalmoscopy Findings - Vitreous (Study Eye)</title>
        <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's vitreous</description>
        <time_frame>Baseline, POD 90/Early termination</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Depot</title>
            <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
          </group>
          <group group_id="O2">
            <title>Prednisolone Drops 1% (Standard of Care)</title>
            <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
          </group>
        </group_list>
        <measure>
          <title>Dilated Opthalmoscopy Findings - Vitreous (Study Eye)</title>
          <description>The number and percentage of patients with normal or abnormal findings from dilated opthalmoscopy examination of the study eye's vitreous</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening (Baseline)</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="104"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative day 90/End of treatment</title>
              <category_list>
                <category>
                  <title>Normal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abnormal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not analyzed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected from screening until postoperative day 90/end of treatment.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dexamethasone Depot</title>
          <description>A single intraocular dose of dexamethasone (517 mcg) at the conclusion of cataract surgery</description>
        </group>
        <group group_id="E2">
          <title>Prednisolone Drops 1% (Standard of Care)</title>
          <description>Three weeks of treatment with prednisolone drops 1% (one drop, four times daily for three weeks)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vice President, Quality and Compliance</name_or_title>
      <organization>Icon Bioscience, Inc.</organization>
      <phone>510-933-8381</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

